All News
Filter News
Found 808,448 articles
-
Vertex Release: The New England Journal of Medicine Publishes Data From Two Phase 3 Studies Of ORKAMBITM (Lumacaftor/Ivacaftor) In People With Cystic Fibrosis Who Have Two Copies Of The F508del Mutation
5/18/2015
-
Four Biotech Stocks Advancing New Therapies In The Fight Against Cancer
5/18/2015
-
Mylan Chairman Tells Investors He Would Consider Buying Rival Teva
5/18/2015
-
Mismatch Between Job Culture and Job Seekers
5/18/2015
-
SoCal's Celladon Slashes 50% of Workforce to Conserve Capital After Gene Therapy Fails
5/18/2015
-
Daiichi Sankyo Release: MOVANTIK (naloxegol) Safety Analyses Of Opioid-Induced Constipation Patients 65 And Older With Chronic Non-Cancer Pain
5/18/2015
-
University of Washington Release: Results From The First New Therapeutic Trials In Primary Biliary Cirrhosis (PBC) In A Decade To Be Presented At Digestive Disease Week (DDW)
5/18/2015
-
Eleven Biotherapeutics Announces Top-Line Results From Pivotal Phase 3 Study Of EBI-005 In Patients With Moderate To Severe Dry Eye Disease
5/18/2015
-
Here's Why Gilead Should Avoid Bigger Deals and Focus on Smaller Cancer-Focused Buyouts
5/18/2015
-
Theravance Biopharma Presents Positive Phase 2 Study Data On Velusetrag (TD-5108) For Treatment Of Gastroparesis In "Poster Of Distinction" At Digestive Disease Week (DDW) 2015
5/18/2015
-
Marinus Pharmaceuticals Presents Clinical Data Of Ganaxolone In Pediatric Epilepsies At Antiepileptic Drug And Device Trials XIII Conference
5/18/2015
-
Intra-Cellular Therapies, Inc. Announces Further Analyses Of The Phase II Clinical Trial Of ITI-007 In Schizophrenia At The 168th Annual Meeting Of The American Psychiatric Association
5/18/2015
-
How GlaxoSmithKline's Much-Criticized Chief's Strategy Differs From His Peers
5/18/2015
-
Alnylam Files Clinical Trial Application (CTA) for ALN-AAT, An Investigational RNAi Therapeutic For The Treatment Of Alpha-1 Antitrypsin Deficiency-Associated Liver Disease (Alpha-1 Liver Disease)
5/18/2015
-
Baxter International Receives U.S. FDA Approval for 0.9% Sodium Chloride Injection, USP From Sabinanigo, Spain, Facility For The U.S. Market
5/18/2015
-
Patrick Soon-Shiong's NantPharma Snaps Up Rights to Sorrento's Cynviloq in Deal Worth $1.3 Billion+
5/18/2015
-
Arterial Remodeling Technologies (ART) Announces CE Mark Clearance For Its Pure Bioresorbable Scaffold
5/18/2015
-
Feds Charge Ex-J.P. Morgan Exec, Father in Medtech Insider Trading Scheme
5/18/2015
-
BREAKING: Aegerion CFO Leaving for New Job, Not Forced Out, Says Spokesperson
5/18/2015
-
Boehringer Ingelheim Presents New Data And Analyses Reinforcing The Safety And Efficacy Of OFEV (nintedanib) Capsules
5/18/2015